Rchr
J-GLOBAL ID：201401074851669410
Update date: Mar. 20, 2024
Ito Tatsuya
イトウ タツヤ | Ito Tatsuya
Affiliation and department：
Research field (1)：
Medical equipment testing
Research theme for competitive and other funds (3)：
- 2021 - 2024 Regulatory Systems and Education Environment for Promoting Research Integrity
- 2017 - 2021 Establishing a governance system for residual biospecimens and health information based on trust through value sharing with the public
- 2017 - 2021 Legislation comparison of research integrity in Europe and development of research integrity in Japan
Papers (24)：
-
Hidehiro Someko, Norio Yamamoto, Tatsuya Ito, Tomoharu Suzuki, Takahiro Tsuge, Hajime Yabuzaki, Eisuke Dohi, Yuki Kataoka. Misleading presentations in functional food trials led by contract research organizations were frequently observed in Japan: meta-epidemiological study. Journal of Clinical Epidemiology. 2024. 169. 111302-111302
-
Hiroki Yamanaka, Eiichi Sawaragi, Takashi Nakano, Yasuhiro Katayama, Tatsuya Ito, Harue Tada, Yu Hidaka, Satoshi Morita, Chihiro Funakoshi, Akemi Kinoshita, et al. A high-hydrostatic pressure device for nevus tissue inactivation and dermal regeneration for reconstructing skin defects after giant congenital melanocytic nevus excision: a clinical trial. Regenerative Therapy. 2023. 24. 167-173
-
Ryosuke Kurauchi, Hiroi Kasai, Tatsuya Ito. Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports. Frontiers in Bioengineering and Biotechnology. 2020. 8
-
Lara Bernasconi, Selçuk Şen, Luca Angerame, Apolo P. Balyegisawa, Damien Hong Yew Hui, Maximilian Hotter, Chung Y. Hsu, Tatsuya Ito, Francisca Jörger, Wolfgang Krassnitzer, et al. Legal and ethical framework for global health information and biospecimen exchange - an international perspective. BMC Medical Ethics. 2020. 21. 1
-
Tatsuya Ito, Gillian Tallents, Liam McKervey, Rachel Davies, Anna Brooke, Jessica Bisset, Jake Harley, Birgit Whitman. A case study comparing research integrity, governance and ethics frameworks to facilitate collaboration between Bristol and Kyoto University. Clinical Ethics. 2017. 12. 4. 205-216
ｍore...
MISC (21)：
-
伊藤 達也, 池田浩治, 菅原岳史, 伊師賢樹, 山地学, 植田康平, 岡田潔, 名井陽. 橋渡し支援拠点間連携としてのARO薬事専門家連絡会の活動. 第1回RSのあり方研究会. 2017
-
伊藤 達也. アカデミアにおける臨床開発支援 ~希少疾病薬レプチンの開発~. 第31回日本薬剤学会学術大会. 2016
-
Tatsuya Ito. Differences of characteristics in investigator-initiated trials between Japan and other countries. 28th DIA Annual EuroMeeting. 2016
-
Tatsuya Ito, Gillian Tallents, Liam McKervey, Rachel Davies, Jessica Bisset, Jake Harley, Diana Benton, Birgit Whitman. Comparison of the research governance frameworks for research involving humans, their tissue and/or data in the UK and Japan. 27th DIA Annual EuroMeeting. 2015
-
N. Morimoto, K. Yoshimura, M. Niimi, T. Ito, R. Aya, J. Fujitaka, H. Tada, S. Teramukai, T. Murayama, C. Toyooka, et al. Tissue Engineering (vol 19, pg 1931, 2013). TISSUE ENGINEERING PART A. 2014. 20. 13-14. 2030-2030
ｍore...
Lectures and oral presentations (5)：
-
アカデミアにおける臨床開発の実践 ~希少疾病薬レプチンの開発~
(長崎大学医歯薬学総合研究科アカデミア創薬ユニット 第1回アカデミア創薬シンポジウム 2016)
-
臨床中核病院事業における取り組み
(第15回CRC養成フォローアップ研修会プログラム 2013)
-
京都大学病院における希少疾病薬開発
(第4回日本臨床試験研究会学術集会 2013)
-
再生医療を早期に臨床応用へと繋ぐための橋渡し研究
(第2回DDS徐放化再生医療研究会 2012)
-
高度医療評価制度下で実施する臨床試験の支援 -希少難治性疾患領域の臨床試験を支援する-
(研究者主導臨床試験の支援シリーズセミナー 2011)
Professional career (1)：
Work history (5)：
- 2023/04 - 現在 Wakayama Medical University School of Pharmaceutical Sciences Professor
- 2020/04 - 2023/03 Kyoto University
- 2016/10 - 2020/03 Kyoto University
- 2013/04 - 2015/09 Kyoto University
- 2007/01 - 2013/03 Kyoto University
Return to Previous Page
